Ralph B. Arlinghaus

Person

Bellaire, TX, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
- Patent number 8,859,727
- Issue date Oct 14, 2014
- The Board of Regents of the University of Texas System
- Jacki Lin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
- Patent number 8,338,366
- Issue date Dec 25, 2012
- The Board of Regents of the University of the Texas System
- Jacki Lin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Inhibition of chronic myelogenous leukemic cell growth by liposomal...
- Patent number 7,923,548
- Issue date Apr 12, 2011
- Board of Regents, The University of Texas System
- Gabriel Lopez-Berestein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for eliciting immune or anti-infective res...
- Patent number 7,319,000
- Issue date Jan 15, 2008
- Board of Regents, The University of Texas System
- Jagannadha K. Sastry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibition of chronic myelogenous leukemic cell growth by liposomal...
- Patent number 7,309,692
- Issue date Dec 18, 2007
- Board of Regents, The University of Texas System
- Gabriel Lopez-Berestein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HIV-specific T-cell induction
- Patent number 7,306,804
- Issue date Dec 11, 2007
- Board of Regents, The University of Texas System
- K. Jagannadha Sastry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibition of chronic myelogenous leukemic cell growth by liposomal...
- Patent number 7,220,853
- Issue date May 22, 2007
- Board of Regents, The University of Texas System
- Gabriel Lopez-Berestein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HIV-specific T-cell induction
- Patent number 6,656,471
- Issue date Dec 2, 2003
- Board of Regents, The University of Texas System
- K. Jagannadha Sastry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
BCR-ABL directed compositions and uses for inhibiting Philadelphia...
- Patent number 6,537,804
- Issue date Mar 25, 2003
- Board of Regents, The University of Texas Systems
- Ralph B. Arlinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prophylaxis and therapy of acquired immunodeficiency syndrome
- Patent number 6,265,539
- Issue date Jul 24, 2001
- The University of Texas System The Board of Regents
- Ralph B. Arlinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for the priming of specific cytotoxic T-ly...
- Patent number 6,210,873
- Issue date Apr 3, 2001
- Board of Regents, The University of Texas System
- Jagannadha K. Sastry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bcr-Abl directed compositions and uses for inhibiting Philadelphia...
- Patent number 6,107,457
- Issue date Aug 22, 2000
- Board of Regents, The University of Texas System
- Ralph B. Arlinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD4 peptides for binding to viral envelope proteins
- Patent number 5,603,933
- Issue date Feb 18, 1997
- Board of Regents, The University of Texas
- Victor A. Dwyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the detection of BCR-ABL and abnormal ABL proteins in l...
- Patent number 5,369,008
- Issue date Nov 29, 1994
- Board of Regents, The University of Texas System
- Ralph B. Arlinghaus
- G01 - MEASURING TESTING
Information Patent Grant
Prophylaxis and therapy of acquired immunodeficiency syndrome
- Patent number 5,128,319
- Issue date Jul 7, 1992
- Board of Regents, The University of Texas System
- Ralph B. Arlinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for the preparation and use of site-direct...
- Patent number 5,126,399
- Issue date Jun 30, 1992
- Board of Regents, The University of Texas System
- Ralph B. Arlinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Prophylaxis Against Cancer Metastasis
- Publication number 20170088623
- Publication date Mar 30, 2017
- InGeneron, Inc.
- Eckhard U. Alt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOACTIVE FUS1 PEPTIDES AND NANOPARTICLE-POLYPEPTIDE COMPLEXES
- Publication number 20130266634
- Publication date Oct 10, 2013
- Jacki LIN
- B82 - NANO-TECHNOLOGY
Information Patent Application
Prophylaxis Against Cancer Metastasis
- Publication number 20120219561
- Publication date Aug 30, 2012
- InGeneron, Inc.
- Eckhard U. Alt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics
- Publication number 20080274104
- Publication date Nov 6, 2008
- Ralph B. Arlinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal...
- Publication number 20070238686
- Publication date Oct 11, 2007
- Gabriel Lopez-Berestein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
- Publication number 20060251726
- Publication date Nov 9, 2006
- Jacki Lin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIV-specific T-cell induction
- Publication number 20050032039
- Publication date Feb 10, 2005
- K. Jagannadha Sastry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bcr-Abl directed compositions and uses for inhibiting Philadelphia...
- Publication number 20040022772
- Publication date Feb 5, 2004
- Ralph B. Arlinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of chronic myelogenous leukemic cell growth by liposomal...
- Publication number 20030153526
- Publication date Aug 14, 2003
- Gabriel Lopez-Berestein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prophylaxis and therapy of acquired immunodeficiency syndrome
- Publication number 20020151678
- Publication date Oct 17, 2002
- Board of Regents, The University of Texas System
- Ralph B. Arlinghaus
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Ralph B. Arlinghaus

Person

Patents Grantslast 30 patents

Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

Inhibition of chronic myelogenous leukemic cell growth by liposomal...

Compositions and methods for eliciting immune or anti-infective res...

Inhibition of chronic myelogenous leukemic cell growth by liposomal...

HIV-specific T-cell induction

Inhibition of chronic myelogenous leukemic cell growth by liposomal...

HIV-specific T-cell induction

BCR-ABL directed compositions and uses for inhibiting Philadelphia...

Prophylaxis and therapy of acquired immunodeficiency syndrome

Methods and compositions for the priming of specific cytotoxic T-ly...

Bcr-Abl directed compositions and uses for inhibiting Philadelphia...

CD4 peptides for binding to viral envelope proteins

Methods for the detection of BCR-ABL and abnormal ABL proteins in l...

Prophylaxis and therapy of acquired immunodeficiency syndrome

Methods and compositions for the preparation and use of site-direct...

Patents Applicationslast 30 patents

Prophylaxis Against Cancer Metastasis

BIOACTIVE FUS1 PEPTIDES AND NANOPARTICLE-POLYPEPTIDE COMPLEXES

Prophylaxis Against Cancer Metastasis

Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics

Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal...

Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

HIV-specific T-cell induction

Bcr-Abl directed compositions and uses for inhibiting Philadelphia...

Inhibition of chronic myelogenous leukemic cell growth by liposomal...

Prophylaxis and therapy of acquired immunodeficiency syndrome